Template:Psoriasis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 106: Line 106:
!
!
[[Psoriasis X-ray|X-ray]]
[[Psoriasis X-ray|X-ray]]
|-
!
|- bgcolor="LightSkyBlue"
!
[[Psoriasis ultrasound|Ultrasound]]
|-  
|-  
!
!
Line 159: Line 165:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Psoriasis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
[[Psoriasis secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!  
Line 165: Line 171:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Psoriasis future or investigational therapies|Future or Investigational Therapies]]
[[Psoriasis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-  
|-  
!
!  


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
[[Psoriasis social impact|Social Impact]]
[[Psoriasis future or investigational therapies|Future or Investigational Therapies]]
|-  
|-  
!  
!


|- bgcolor="CadetBlue"
|- bgcolor="CadetBlue"

Latest revision as of 15:52, 23 August 2017